当前位置:首页 - 行情中心 - 峆一药业(430478) - 财务分析 - 现金流量表

峆一药业

(430478)

  

流通市值:10.49亿  总市值:17.50亿
流通股本:4720.61万   总股本:7870.87万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金185,289,389.890,095,716.87247,668,018.53207,663,331.45
  收到的税费返还10,829,843.036,739,803.8314,444,992.878,969,300.15
  收到其他与经营活动有关的现金2,281,261.452,150,688.513,833,212.685,546,827.35
  经营活动现金流入小计198,400,494.2898,986,209.21265,946,224.08222,179,458.95
  购买商品、接受劳务支付的现金87,875,030.4147,527,984.85129,799,440.64119,277,745.99
  支付给职工以及为职工支付的现金27,933,538.9914,106,603.0948,277,684.0336,382,138.04
  支付的各项税费10,852,305.735,285,317.9922,724,192.9414,987,939.22
  支付其他与经营活动有关的现金11,693,599.297,014,528.223,682,896.0419,760,921.84
  经营活动现金流出小计138,354,474.4273,934,434.13224,484,213.65190,408,745.09
  经营活动产生的现金流量净额60,046,019.8625,051,775.0841,462,010.4331,770,713.86
二、投资活动产生的现金流量:
  收回投资收到的现金252,000,000137,000,000586,000,000486,000,000
  取得投资收益收到的现金1,796,012.441,426,611.022,804,722.182,692,577.69
  处置固定资产、无形资产和其他长期资产收回的现金净额8908905,0005,000
  收到的其他与投资活动有关的现金81,585.3247,428.41-449,471.95
  投资活动现金流入小计253,878,487.76138,474,929.43588,809,722.18489,147,049.64
  购建固定资产、无形资产和其他长期资产支付的现金77,697,769.6520,075,703.3944,801,604.827,654,169.87
  投资支付的现金213,330,000123,000,000567,000,000437,000,000
  投资活动现金流出小计291,027,769.65143,075,703.39611,801,604.82444,654,169.87
  投资活动产生的现金流量净额-37,149,281.89-4,600,773.96-22,991,882.6444,492,879.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金--4,685,590-
  取得借款收到的现金16,202,514.89---
  收到其他与筹资活动有关的现金--4,832,075.026,490,301.08
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计16,202,514.89-9,517,665.026,490,301.08
  分配股利、利润或偿付利息支付的现金22,488,200-11,063,00016,063,000
  支付其他与筹资活动有关的现金6,673,837.93458,277.977,801,561.996,669,460.29
  筹资活动现金流出小计29,162,037.93458,277.9718,864,561.9922,732,460.29
  筹资活动产生的现金流量净额-12,959,523.04-458,277.97-9,346,896.97-16,242,159.21
四、汇率变动对现金及现金等价物的影响909,071.61434,846.52,273,938.471,556,037.14
五、现金及现金等价物净增加额10,846,286.5420,427,569.6511,397,169.2961,577,471.56
  加:期初现金及现金等价物余额69,703,538.6969,703,538.6958,306,369.458,306,369.4
  期末现金及现金等价物余额80,549,825.2390,131,108.3469,703,538.69119,883,840.96
补充资料:
  净利润38,455,298.38-44,633,212.97-
  资产减值准备-161,456.34-2,963,536.99-
  固定资产和投资性房地产折旧10,342,251.74-20,582,929.93-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,342,251.74-20,582,929.93-
  无形资产摊销387,820.16-683,558.32-
  长期待摊费用摊销354,351.62-416,156.98-
  固定资产报废损失11,502.28-119,991.58-
  公允价值变动损失606,856--460,620.39-
  财务费用-927,414.19--2,137,010.6-
  投资损失-1,796,012.44--3,324,305.74-
  递延所得税-301,721.26--69,612.11-
  其中:递延所得税资产减少-312,222.93--5,514.91-
    递延所得税负债增加10,501.67--64,097.2-
  存货的减少-792,402.46-310,509.59-
  经营性应收项目的减少6,592,091.63--24,674,855.44-
  经营性应付项目的增加4,995,365.76--469,215.21-
  其他2,040,720.33-765,270.13-
  现金的期末余额80,549,825.23-69,703,538.69-
  减:现金的期初余额69,703,538.69-58,306,369.4-
  现金及现金等价物的净增加额10,846,286.54-11,397,169.29-
公告日期2025-08-192025-04-282025-04-182024-10-28
审计意见(境内)标准无保留意见
TOP↑